Amphastar Pharmaceuticals, Inc. vs. Aegis Therapeutics, LLC et al.
Explore the PTAB proceeding IPR2021-01324 filed by Amphastar Pharmaceuticals, Inc. on 2021-08-12. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2021-01324
Filing Date
2021-08-12
Accorded Filing Date
2021-08-12
Institution Decision Date
2022-02-14
Last Modified Date
2026-10-30
Proceeding Type
IPR
Termination Date
2023-02-09
Trial Status
Final Written Decision
Parties & Counsel
Petitioner
Amphastar Pharmaceuticals, Inc.
Represented By
Greb, Emilyet alPatent Owner / Respondent
Aegis Therapeutics, LLC et al.
Represented By
Jenkins, Kennethet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
3 Total
Proceeding Status
Final Written Decision
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (3)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 32483 | Vernon Norviel | +1 650-320-4704 |
| 34448 | Richard Torczon Jr | +1 202-973-8811 |
| 39666 | Um Ping Eng | +1 650-493-9300 |
| 42296 | William Barrett | +1 650-771-9816 |
| 44409 | Karen Wong | +1 650-493-9300 |
| 47664 | Michael Hostetler | +1 858-350-2306 |
| 52182 | Michael Rosato | +1 206-883-2529 |
| 52353 | Lorelei Westin | +1 858-350-2225 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 10 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 10,682,414 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,191,838 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,744,895 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,717,571 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 12,324,838 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,918,655 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2025026230 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 10,576,156 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2018627840 | US Continuation / Sibling | View Official Patent → |
| ๐ PCT International (WIPO) | WO 2019157099 A1 | PCT World Application | View Official Patent → |
ARS PHARMACEUTICALS OPERATIONS, INC. v. LUPIN INC.